Works by Yajima, Toshitaka

Results: 39

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.

Published in:

Journal of Diabetes Investigation, 2016, v. 7, n. 4, p. 555, doi. 10.1111/jdi.12453

By:

Araki, Eiichi;
Onishi, Yukiko;
Asano, Michiko;
Kim, Hyosung;
Ekholm, Ella;
Johnsson, Eva;
Yajima, Toshitaka

Publication type:

Article

Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein.

Published in:

EMBO Journal, 2004, v. 23, n. 22, p. 4517, doi. 10.1038/sj.emboj.7600454

By:

Pradervand, Sylvain;
Yasukawa, Hideo;
Muller, Olivier G.;
Kjekshus, Harald;
Nakamura, Tomoyuki;
St. Amand, Tara R.;
Yajima, Toshitaka;
Matsumura, Kiyoyuki;
Duplain, Hervé;
Iwatate, Mitsuo;
Woodard, Sarah;
Pedrazzini, Thierry;
Ross, John;
Firsov, Dmitri;
Rossier, Bernard C.;
Hoshijima, Masahiko;
Chien, Kenneth R.

Publication type:

Article

Oral esomeprazole in Japanese pediatric patients with gastric acid‐related disease: Safety, efficacy, and pharmacokinetics.

Published in:

Pediatrics International, 2019, v. 61, n. 1, p. 87, doi. 10.1111/ped.13733

By:

Shimizu, Toshiaki;
Nakayama, Yoshiko;
Ishii, Eizaburo;
Ida, Shinobu;
Satou, Tomoki;
Tokuhara, Daisuke;
Arai, Katsuhiro;
Nii, Masahiro;
Rydholm, Hans;
Yajima, Toshitaka

Publication type:

Article

Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 9, p. 2424, doi. 10.1210/clinem/dgac420

By:

Tomoya Mita;
Naoto Katakami;
Mitsuyoshi Takahara;
Masaru Kawashima;
Fumitaka Wada;
Hiroki Akiyama;
Naru Morita;
Yoko Kidani;
Toshitaka Yajima;
Iichiro Shimomura;
Hirotaka Watada

Publication type:

Article

Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia.

Published in:

Nutrients, 2022, v. 14, n. 21, p. 4614, doi. 10.3390/nu14214614

By:

Kanda, Eiichiro;
Okami, Suguru;
Kohsaka, Shun;
Okada, Masafumi;
Ma, Xiaojun;
Kimura, Takeshi;
Shirakawa, Koichi;
Yajima, Toshitaka

Publication type:

Article

206-LB: Cardiorenal Disease Is the Most Common First CV Manifestation in Type 2 Diabetes and Associated with Increased Mortality: A Large Multinational Observational Study.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-206-LB

By:

BIRKELAND, KARE I.;
BODEGARD, JOHAN;
THURESSON, MARCUS;
ERIKSSON, JAN W.;
NORHAMMAR, ANNA;
YAJIMA, TOSHITAKA;
KOMURO, ISSEI;
KADOWAKI, TAKASHI

Publication type:

Article

A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.

Published in:

Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 140, doi. 10.1007/s10157-020-01972-y

By:

Kashihara, Naoki;
Yamasaki, Yoshimitsu;
Osonoi, Takeshi;
Harada, Hiromasa;
Shibagaki, Yugo;
Zhao, June;
Kim, Hyosung;
Yajima, Toshitaka;
Sarai, Nobuaki

Publication type:

Article

Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study.

Published in:

Clinical & Experimental Nephrology, 2020, v. 24, n. 12, p. 1144, doi. 10.1007/s10157-020-01937-1

By:

Kashihara, Naoki;
Nishio, Toshiki;
Osonoi, Takeshi;
Saka, Yosuke;
Imasawa, Toshiyuki;
Ohtake, Takayasu;
Mizuno, Hiroshi;
Shibagaki, Yugo;
Kim, Hyosung;
Yajima, Toshitaka;
Sarai, Nobuaki

Publication type:

Article

Andexanet alfa (ONDEXXYA® for Intravenous Injection 200 mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence.

Published in:

Folia Pharmacologica Japonica, 2023, v. 158, n. 1, p. 89, doi. 10.1254/fpj.22107

By:

Toshitaka Yajima;
Mitsuo Higashimori;
Chie Takata;
Toshikazu Sasabe

Publication type:

Article

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.

Published in:

BMC Nephrology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12882-022-03054-5

By:

Kanda, Eiichiro;
Rastogi, Anjay;
Murohara, Toyoaki;
Lesén, Eva;
Agiro, Abiy;
Arnold, Matthew;
Chen, Gengshi;
Yajima, Toshitaka;
Järbrink, Krister;
Pollack Jr, Charles V.

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega‐3‐Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single‐Blind, Randomized, Placebo‐Controlled Trial.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 177, doi. 10.1002/cpdd.360

By:

Noda, Yoshinori;
Nilsson, Catarina;
Shimada, Hitoshi;
Kim, Hyosung;
Lundström, Torbjörn;
Yajima, Toshitaka

Publication type:

Article

Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study.

Published in:

Frontiers in Physiology, 2023, v. 14, p. 1, doi. 10.3389/fphys.2023.1156289

By:

Eiichiro Kanda;
Naru Morita;
Toshitaka Yajima

Publication type:

Article

Treatment patterns and trajectories in patients after acute heart failure hospitalization.

Published in:

ESC Heart Failure, 2024, v. 11, n. 2, p. 692, doi. 10.1002/ehf2.14635

By:

Nakamaru, Ryo;
Shiraishi, Yasuyuki;
Kohno, Takashi;
Nagatomo, Yuji;
Akiyama, Hiroki;
Motoya, Yuki;
Fukui, Masato;
Yajima, Toshitaka;
Yoshikawa, Tsutomu;
Kohsaka, Shun

Publication type:

Article

Correction: Kohsaka et al. Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11 , 5828.

Published in:

2023

By:

Kohsaka, Shun;
Okami, Suguru;
Morita, Naru;
Yajima, Toshitaka

Publication type:

Correction Notice

Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2115, doi. 10.3390/jcm12062115

By:

Iwagami, Masao;
Kanemura, Yuka;
Morita, Naru;
Yajima, Toshitaka;
Fukagawa, Masafumi;
Kobayashi, Shuzo

Publication type:

Article

Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5828, doi. 10.3390/jcm11195828

By:

Kohsaka, Shun;
Okami, Suguru;
Morita, Naru;
Yajima, Toshitaka

Publication type:

Article

Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome.

Published in:

Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1111984

By:

Hiroki Akiyama;
Akihiro Nishimura;
Naru Morita;
Toshitaka Yajima

Publication type:

Article

Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24562-2

By:

Kanda, Eiichiro;
Suzuki, Atsushi;
Makino, Masaki;
Tsubota, Hiroo;
Kanemata, Satomi;
Shirakawa, Koichi;
Yajima, Toshitaka

Publication type:

Article

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698

By:

Norhammar, Anna;
Bodegard, Johan;
Eriksson, Jan W.;
Haller, Hermann;
Linssen, Gerard C. M.;
Banerjee, Amitava;
Karasik, Avraham;
Mamouris, Pavlos;
Tangri, Navdeep;
Taveira‐Gomes, Tiago;
Maggioni, Aldo P.;
Botana, Manuel;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka;
Kadowaki, Takashi;
Birkeland, Kåre I.

Publication type:

Article

Current trends in diabetes mellitus database research in Japan.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 3, doi. 10.1111/dom.14325

By:

Kohsaka, Shun;
Morita, Naru;
Okami, Suguru;
Kidani, Yoko;
Yajima, Toshitaka

Publication type:

Article

Healthcare resource utilization after initiation of sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors or other glucose‐lowering drugs in Japanese patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 28, doi. 10.1111/dom.14289

By:

Kohsaka, Shun;
Takeda, Masayoshi;
Kidani, Yoko;
Yajima, Toshitaka

Publication type:

Article

Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119

By:

Komuro, Issei;
Kadowaki, Takashi;
Bodegård, Johan;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka

Publication type:

Article

Current trends in diabetes mellitus database research in Japan.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 3, doi. 10.1111/dom.14325

By:

Kohsaka, Shun;
Morita, Naru;
Okami, Suguru;
Kidani, Yoko;
Yajima, Toshitaka

Publication type:

Article

Healthcare resource utilization after initiation of sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors or other glucose‐lowering drugs in Japanese patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 28, doi. 10.1111/dom.14289

By:

Kohsaka, Shun;
Takeda, Masayoshi;
Kidani, Yoko;
Yajima, Toshitaka

Publication type:

Article

Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119

By:

Komuro, Issei;
Kadowaki, Takashi;
Bodegård, Johan;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka

Publication type:

Article

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189

By:

Birkeland, Kåre I.;
Bodegard, Johan;
Banerjee, Amitava;
Kim, Dae Jung;
Norhammar, Anna;
Eriksson, Jan W.;
Thuresson, Marcus;
Okami, Suguru;
Ha, Kyoung Hwa;
Kossack, Nils;
Mamza, Jil Billy;
Zhang, Ruiqi;
Yajima, Toshitaka;
Komuro, Issei;
Kadowaki, Takashi

Publication type:

Article

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074

By:

Birkeland, Kåre I.;
Bodegard, Johan;
Eriksson, Jan W.;
Norhammar, Anna;
Haller, Hermann;
Linssen, Gerard C.M.;
Banerjee, Amitava;
Thuresson, Marcus;
Okami, Suguru;
Garal‐Pantaler, Elena;
Overbeek, Jetty;
Mamza, Jil Billy;
Zhang, Ruiqi;
Yajima, Toshitaka;
Komuro, Issei;
Kadowaki, Takashi

Publication type:

Article

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 540, doi. 10.1111/dom.13922

By:

Araki, Eiichi;
Watada, Hirotaka;
Uchigata, Yasuko;
Tomonaga, Osamu;
Fujii, Hitomi;
Ohashi, Hiroshi;
Okabe, Tadashi;
Asano, Michiko;
Thoren, Fredrik;
Kim, Hyosung;
Yajima, Toshitaka;
Langkilde, Anna Maria

Publication type:

Article

Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 876, doi. 10.1111/dom.13593

By:

Watada, Hirotaka;
Shiramoto, Masanari;
Ueda, Shinya;
Tang, Weifeng;
Asano, Michiko;
Thorén, Fredrik;
Kim, Hyosung;
Yajima, Toshitaka;
Boulton, David W.;
Araki, Eiichi

Publication type:

Article

Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 562, doi. 10.1111/dom.12853

By:

Araki, Eiichi;
Onishi, Yukiko;
Asano, Michiko;
Kim, Hyosung;
Yajima, Toshitaka

Publication type:

Article

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan.

Published in:

Diabetes Therapy, 2022, v. 13, n. 7, p. 1367, doi. 10.1007/s13300-022-01270-8

By:

Igarashi, Ataru;
Maruyama-Sakurai, Keiko;
Kubota, Anna;
Akiyama, Hiroki;
Yajima, Toshitaka;
Kohsaka, Shun;
Miyata, Hiroaki

Publication type:

Article

Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER.

Published in:

Diabetes Therapy, 2022, v. 13, n. 2, p. 251, doi. 10.1007/s13300-021-01192-x

By:

Takahara, Mitsuyoshi;
Mita, Tomoya;
Katakami, Naoto;
Wada, Fumitaka;
Morita, Naru;
Kidani, Yoko;
Yajima, Toshitaka;
Shimomura, Iichiro;
Watada, Hirotaka

Publication type:

Article

Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database.

Published in:

Diabetes Therapy, 2022, v. 13, n. 2, p. 275, doi. 10.1007/s13300-021-01191-y

By:

Kadowaki, Takashi;
Komuro, Issei;
Morita, Naru;
Akiyama, Hiroki;
Kidani, Yoko;
Yajima, Toshitaka

Publication type:

Article

Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study.

Published in:

Diabetes Therapy, 2020, v. 11, n. 7, p. 1563, doi. 10.1007/s13300-020-00846-6

By:

Katakami, Naoto;
Mita, Tomoya;
Takahara, Mitsuyoshi;
Yajima, Toshitaka;
Wada, Fumitaka;
Kawashima, Masaru;
Shimomura, Iichiro;
Watada, Hirotaka

Publication type:

Article

Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study.

Published in:

Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 154, doi. 10.1159/000484047

By:

Yokoyama, Tadashi;
Ohta, Akihiko;
Motoya, Satoshi;
Takazoe, Masakazu;
Yajima, Toshitaka;
Date, Masataka;
Nii, Masahiro;
Nagy, Péter;
Suzuki, Yasuo;
Hibi, Toshifumi

Publication type:

Article

Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study.

Published in:

Journal of Diabetes Investigation, 2021, v. 12, n. 1, p. 67, doi. 10.1111/jdi.13321

By:

Kohsaka, Shun;
Takeda, Masayoshi;
Bodegård, Johan;
Thuresson, Marcus;
Kosiborod, Mikhail;
Yajima, Toshitaka;
Wittbrodt, Eric;
Fenici, Peter

Publication type:

Article

Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.

Published in:

Journal of Clinical Investigation, 2013, v. 123, n. 12, p. 5146, doi. 10.1172/JCI66271

By:

Byung-Kwan Lim;
Peter, Angela K.;
Dingding Xiong;
Narezkina, Anna;
Aaron Yung;
Dalton, Nancy D.;
Kyung-Kuk Hwang;
Toshitaka Yajima;
Ju Chen;
Knowlton, Kirk U.

Publication type:

Article

An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice.

Published in:

2008

By:

Sheikh, Farah;
Raskin, Anna;
Chu, Pao-Hsien;
Lange, Stephan;
Domenighetti, Andrea A.;
Zheng, Ming;
Liang, Xingqun;
Zhang, Tong;
Yajima, Toshitaka;
Gu, Yusu;
Dalton, Nancy D.;
Mahata, Sushil K.;
Dorn II, Gerald W.;
Heller-Brown, Joan;
Peterson, Kirk L.;
Omens, Jeffrey H.;
McCulloch, Andrew D.;
Chen, Ju;
Dorn, Gerald W 2nd;
Brown, Joan Heller

Publication type:

journal article

Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart.

Published in:

2008

By:

Byung-Kwan Lim;
Dingding Xiong;
Dorner, Andrea;
Tae-Jin Youn;
Yung, Aaron;
Liu, Taylor I.;
Yusu Gu;
Dalton, Nancy D.;
Wright, Adam T.;
Evans, Sylvia M.;
Ju Chen;
Peterson, Kirk L.;
McCulloch, Andrew D.;
Yajima, Toshitaka;
Knowlton, Kirk U.;
Lim, Byung-Kwan;
Xiong, Dingding;
Youn, Tae-Jin;
Gu, Yusu;
Chen, Ju

Publication type:

journal article